Provision of Assay Kits for SCID Evaluation

Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to Immunoivd AB commencing 01/10/2026 to 31/03/2027 NHS England will submit the UK07 notice at the earliest opportunity afforded by the e-notification systems.

Supply of Spot-IT Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 3 Screening laboratories.